TargAnox Garners $5,100,000 Series A Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    101 Huntington Avenue, 4th Floor Boston, MA 02199
  • Company Description
    TargAnox is focused on developing drugs to curb a sometimes disease-related biochemical condition called oxidative stress.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Ascent Biomedical Ventures
  • Venture Investor
    Partners Innovation Fund
  • Venture Investor
    Partners HealthCare System

By posting a comment, you agree to our terms and conditions.